January 13, 2021
As the Ohio Department of Health’s phased approach to vaccination moves from Phase 1A to Phase 1B, the vaccine will be offered to a broader cross-section of the community beginning the week of Jan. 19.
January 12, 2021
The virtual town hall will be Friday, Jan. 15 at 10 a.m. to update faculty and staff on plans for the spring semester and the status of the University’s COVID-19 response and vaccine distribution plans.
January 11, 2021
The antigen-based tests, performed in partnership with The University of Toledo Medical Center and collected via a shallow nasal swab, will provide results in approximately 30 minutes.
January 7, 2021
Dr. Michael Ellis, an infectious disease specialist and chief medical officer at UTMC, talks about the hospital’s participation in a nationwide NIH study examining a pair of monoclonal antibodies to treat COVID-19. The study is aimed at quickly identifying therapeutics worthy of larger clinical trials. Read: UTMC patients part of national study on COVID drugs
January 6, 2021
Experts from The University of Toledo will answer questions about the COVID-19 pandemic during a virtual town hall on Jan. 7. Read: UT to hold second coronavirus Town Hall online
January 6, 2021
Dr. Michael Ellis, an infectious disease specialist and chief medical officer at UTMC, talks about hospital’s participation in a nationwide NIH study aimed at quickly and efficiently identifying additional therapeutics for COVID-19 worthy of larger clinical trials.
January 6, 2021
Dr. Michael Ellis, an infectious disease specialist and chief medical officer at UTMC, talks about the importance of developing new COVID-19 therapies and how UTMC is playing a role by participating in a nationwide NIH study of experimental treatments.
January 6, 2021
Experts from The University of Toledo will answer questions about the COVID-19 pandemic during a virtual town hall on Jan. 7. Read: UT hosting another virtual COVID-19 town hall
January 5, 2021
The proof-of-concept study is intended to quickly screen out ineffective experimental treatments while rapidly advancing the deployment of therapeutics that show significant benefit to hospitalized COVID-19 patients.
December 23, 2020
The event hosted by the University of Toledo Foundation is free and open to the public, though registration is required.
